LIMACRYL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LIMACRYL
Largest movements
- Receivables within one year -€9,263
down €9,263 (-3.0%), from €309,263 to €300,000
- Profit (loss) carried forward -€12,071
down €12,071 (-126.8%), from -€9,520 to -€21,592
- Financial income -€3,000
down €3,000 (-20.0%), from €15,000 to €12,000
- Gross operating margin +€887
up €887 (+17.2%), from -€5,160 to -€4,273
- Other operating charges +€265
up €265 (+1.4%), from €19,164 to €19,429
- Financial charges +€135
up €135 (+68.8%), from €196 to €331
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €391,707 | €379,636 | -€12,071 | -3.1% |
| Fixed assets | 21/28 | €44,621 | €44,621 | = | 0.0% |
| Tangible fixed assets | 22/27 | €44,621 | €44,621 | = | 0.0% |
| Land and buildings | 22 | €44,621 | €44,621 | = | 0.0% |
| Current assets | 29/58 | €347,086 | €335,015 | -€12,071 | -3.5% |
| Amounts receivable within one year | 40/41 | €309,263 | €300,000 | -€9,263 | -3.0% |
| Other amounts receivable | 41 | €309,263 | €300,000 | -€9,263 | -3.0% |
| Cash at bank and in hand | 54/58 | €22,823 | €23,015 | +€192 | +0.8% |
| Deferred charges and accrued income | 490/1 | €15,000 | €12,000 | -€3,000 | -20.0% |
| Total equity and liabilities | 10/49 | €391,707 | €379,636 | -€12,071 | -3.1% |
| Equity | 10/15 | €388,207 | €376,136 | -€12,071 | -3.1% |
| Contributions | 10/11 | €397,000 | €397,000 | = | 0.0% |
| Capital | 10 | €397,000 | €397,000 | = | 0.0% |
| Issued capital | 100 | €397,000 | €397,000 | = | 0.0% |
| Reserves | 13 | €727 | €727 | = | 0.0% |
| Non-distributable reserves | 130/1 | €727 | €727 | = | 0.0% |
| Legal reserve | 130 | €727 | €727 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€9,520 | -€21,592 | -€12,071 | -126.8% |
| Amounts payable | 17/49 | €3,500 | €3,500 | = | 0.0% |
| Amounts payable within one year | 42/48 | €3,500 | €3,500 | = | 0.0% |
| Trade debts | 44 | €3,500 | €3,500 | = | 0.0% |
| Suppliers | 440/4 | €3,500 | €3,500 | = | 0.0% |
| Other operating charges | 640/8 | €19,164 | €19,429 | +€265 | +1.4% |
| Gross operating margin | 9900 | -€5,160 | -€4,273 | +€887 | +17.2% |
| Operating profit (loss) | 9901 | -€24,324 | -€23,702 | +€622 | +2.6% |
| Financial income | 75/76B | €15,000 | €12,000 | -€3,000 | -20.0% |
| Recurring financial income | 75 | €15,000 | €12,000 | -€3,000 | -20.0% |
| Financial charges | 65/66B | €196 | €331 | +€135 | +68.8% |
| Recurring financial charges | 65 | €196 | €331 | +€135 | +68.8% |
| Profit (loss) for the period before taxes | 9903 | -€9,520 | -€12,033 | -€2,513 | -26.4% |
| Income taxes | 67/77 | - | €38 | +€38 | |
| Profit (loss) for the period | 9904 | -€9,520 | -€12,071 | -€2,551 | -26.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€9,520 | -€12,071 | -€2,551 | -26.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.